Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001408234 | SCV001610228 | likely benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV002268482 | SCV002551118 | uncertain significance | not specified | 2024-07-31 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002504681 | SCV002810791 | likely benign | Sessile serrated polyposis cancer syndrome | 2021-11-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001408234 | SCV004145746 | benign | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing | RNF43: BS1, BS2 |
Prevention |
RCV003908592 | SCV004725488 | likely benign | RNF43-related disorder | 2023-03-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |